W. Va. Code R. § 15-8-3

Current through Register Vol. XLI, No. 50, December 13, 2024
Section 15-8-3 - Prescription Monitoring Program
3.1. Each time a Schedule II, III, IV, or V Controlled Substance, drug of concern, or opioid antagonist is dispensed for out-patient use, the medical services provider, health care facility, or pharmacy that dispensed the controlled substance, drug of concern, or opioid antagonist shall transmit to the central repository the information required by West Virginia Code § 60A-9-4 in the appropriate American Society for Automation in Pharmacy format used by the central repository for reporting to it. This includes the following:
3.1.a. The name, address, pharmacy prescription number and Drug Enforcement Administration controlled substance registration number of the dispensing pharmacy or the dispensing medical services provider;
3.1.b. The full legal name, address and birth date of the recipient. When reporting the full legal name, address, and date of birth of the recipient, the reporter shall include any middle name or initial and any suffix (e.g., Jr., II, III) as listed on the patient's government-issued photo identification card If the patient does not have such an identification card, such as a minor, then the reporter shall obtain and input the information to the best of his or her knowledge and ability based upon the information available to it from the prescription, the patient profile or record, and any other information known to the reporter. Examples of acceptable forms of ID include, but are not limited to: driver's licenses, non-driver identification cards, passports, and military IDs;
3.1.c. The Drug Enforcement Administration controlled substances registration number of the practitioner writing the prescription. By providing this registration number, the Controlled Substances Monitoring Program database will extract the prescriber's name and address required by statute; therefore, the reporters do not need to additionally supply the prescriber's name and address in addition to the prescriber's DEA number;
3.1.d. The national drug code number of the Schedule II, III, IV, or V controlled substance, drug of concern, or opioid antagonist dispensed. By providing this NDC number, the Controlled Substances Monitoring Program database will extract the name and dosage or strength of the controlled substance required by the statute such that the reporters do not need to additionally supply the name and dosage;
3.1.e. The quantity of the Schedule II, III, IV, or V controlled substance, drug of concern, or opioid antagonist dispensed;
3.1.f. The date the prescription was written and the date filled;
3.1.g. The number of refills, if any, authorized by the prescription;
3.1.h. If the prescription being dispensed is being picked up by a recipient representative on behalf of the recipient, the first and last name of the recipient representative as set forth on the person's government-issued photo identification card, the appropriate code for the type of ID, the ID number, the appropriate code indicating the relationship of the recipient representative to the patient, and the appropriate code for the issuing jurisdiction of the ID; and
3.1.i. The source of payment for the controlled substance, drug of concern, or opioid antagonist dispensed.
3.2 The board and the central repository shall provide for the electronic transmission of the information required to be provided by and through the use of a toll-free telephone line or other Internet connection.

W. Va. Code R. § 15-8-3